Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses
- 1 July 1999
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 17 (7) , 660-665
- https://doi.org/10.1038/10870
Abstract
Tumor-associated carbohydrate (TAC) antigens are important targets in cancer vaccine efforts. Carbohydrates are, however, frequently poor immunogens, in that they are T-cell–independent antigens. Molecular mimicry of TAC by peptides is an alternative approach to generating anti-carbohydrate immune responses. Here we demonstrate that peptide mimotopes can elicit antibody responses that cross-react with representative human TAC antigens. Primary immunization with such a multiple antigenic peptide, along with QS-21 as adjuvant, elicits cytotoxic antibodies reactive with naturally occurring forms of TAC expressed on tumor cells, and vaccination of mice with peptide mimotopes reduced tumor growth and prolonged host survival in a murine tumor model.Keywords
This publication has 43 references indexed in Scilit:
- GD1α‐replica peptides functionally mimic GD1α, an adhesion molecule of metastatic tumor cells, and suppress the tumor metastasisFEBS Letters, 1998
- Sequential T Cell Response Involved in Tumor Rejection of Sarcoma, Meth A, in Syngeneic MiceJapanese Journal of Cancer Research, 1998
- Induction of anti‐carbohydrate antibodies by phage library‐selected peptide mimicsEuropean Journal of Immunology, 1997
- Role of Repetitive Antigen Patterns for Induction of Antibodies Against AntibodiesThe Journal of Experimental Medicine, 1997
- Endothelial-selectin ligands sialyl Lewisx and sialyl Lewisa are differentiation antigens immunogenic in human melanomaCancer, 1997
- Peptide Libraries Define the Fine Specificity of Anti-polysaccharide Antibodies toCryptococcus neoformansJournal of Molecular Biology, 1996
- Antimetastatic and Antitumor Activities of Interleukin 10 in a Murine Model of Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Anti-idiotypic monoclonal antibody cancer vaccinesSeminars in Cancer Biology, 1995
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- T Cell-Independent Antigens Type 2Annual Review of Immunology, 1995